Targeting CD137 enhances vaccine-elicited anti-respiratory syncytial virus CD8+ T cell responses in aged mice

Journal of Immunology

Volumn 192, Issue 1, 2014, Pages 293-299

  Lee, Sujin ^a,b   Mittler, Robert S ^c   Moore, Martin L ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GAMMA INTERFERON; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 41BB; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VACCINATION; VIRAL CLEARANCE;

EID: 84891050690     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300453     Document Type: Article

References (42)

1. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352: 1749-1759.
2. Glezen, W. P., L. H. Taber, A. L. Frank, and J. A. Kasel. 1986. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140: 543-546.
3. Falsey, A. R., and E. E. Walsh. 2005. Respiratory syncytial virus infection in elderly adults. Drugs Aging 22: 577-587.
4. Cherukuri, A., K. L. Stokes, K. Patton, H. Kuo, K. Sakamoto, S. Lambert, E. Stillman, M. L. Moore, and S. Lee. 2012. An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB/c mice. Immun. Ageing 9: 21.
5. Cherukuri, A., K. Patton, R. A. Gasser, Jr., F. Zuo, J. Woo, M. T. Esser, and R. S. Tang. 2013. Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein. Clin. Vaccine Immunol. 20: 239-247.
6. Falsey, A. R. 1998. Respiratory syncytial virus infection in older persons. Vaccine 16: 1775-1778.
7. Graham, B. S. 2011. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development. Immunol. Rev. 239: 149-166.
8. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315: 77-81.
9. Lukens, M. V., A. C. van de Pol, F. E. Coenjaerts, N. J. Jansen, V. M. Kamp, J. L. Kimpen, J.W. Rossen, L. H. Ulfman, C. E. Tacke, M. C. Viveen, et al. 2010. A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants. J. Virol. 84: 2374-2383.
10. Linton, P. J., and K. Dorshkind. 2004. Age-related changes in lymphocyte development and function. Nat. Immunol. 5: 133-139.
11. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
12. Watts, T. H. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu. Rev. Immunol. 23: 23-68.
13. Vinay, D. S., K. Cha, and B. S. Kwon. 2006. Dual immunoregulatory pathways of 4-1BB signaling. J. Mol. Med. 84: 726-736.
14. Croft, M. 2003. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat. Rev. Immunol. 3: 609-620.
15. Laderach, D., M. Movassagh, A. Johnson, R. S. Mittler, and A. Galy. 2002. 4-1BB co-stimulation enhances human CD8(+) T cell priming by augmenting the proliferation and survival of effector CD8(+) T cells. Int. Immunol. 14: 1155-1167.
16. Wilcox, R. A., K. Tamada, D. B. Flies, G. Zhu, A. I. Chapoval, B. R. Blazar, W. M. Kast, and L. Chen. 2004. Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo. Blood 103: 177-184.
17. Halstead, E. S., Y. M. Mueller, J. D. Altman, and P. D. Katsikis. 2002. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat. Immunol. 3: 536-541.
18. Sharma, S., A. L. Dominguez, and J. Lustgarten. 2006. Aging affect the antitumor potential of dendritic cell vaccination, but it can be overcome by costimulation with anti-OX40 or anti-4-1BB. Exp. Gerontol. 41: 78-84.
19. Lee, S., K. L. Stokes, M. G. Currier, K. Sakamoto, N. W. Lukacs, E. Celis, and M. L. Moore. 2012. Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice. J. Virol. 86: 13016-13024.
20. Ahonen, C. L., C. L. Doxsee, S. M. McGurran, T. R. Riter, W. F. Wade, R. J. Barth, J. P. Vasilakos, R. J. Noelle, and R. M. Kedl. 2004. Combined TLR and CD40 triggering induces potent CD8+ T cell expansion with variable dependence on type I IFN. J. Exp. Med. 199: 775-784.
21. Assudani, D., H. I. Cho, N. DeVito, N. Bradley, and E. Celis. 2008. In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. Cancer Res. 68: 9892-9899.
22. Bansal-Pakala, P., and M. Croft. 2002. Defective T cell priming associated with aging can be rescued by signaling through 4-1BB (CD137). J. Immunol. 169: 5005-5009.
23. Moore, M. L., M. H. Chi, C. Luongo, N. W. Lukacs, V. V. Polosukhin, M. M. Huckabee, D. C. Newcomb, U. J. Buchholz, J. E. Crowe, Jr., K. Goleniewska, et al. 2009. A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction. J. Virol. 83: 4185-4194.
24. Stokes, K. L., M. H. Chi, K. Sakamoto, D. C. Newcomb, M. G. Currier, M. M. Huckabee, S. Lee, K. Goleniewska, C. Pretto, J. V. Williams, et al. 2011. Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J. Virol. 85: 5782-5793.
25. Liu, B., and Y. Kimura. 2007. Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J. Gen. Virol. 88: 2552-2558.
26. Lustgarten, J., A. L. Dominguez, and M. Thoman. 2004. Aged mice develop protective antitumor immune responses with appropriate costimulation. J. Immunol. 173: 4510-4515.
27. Salek-Ardakani, S., M. Moutaftsi, A. Sette, and M. Croft. 2011. Targeting OX40 promotes lung-resident memory CD8 T cell populations that protect against respiratory poxvirus infection. J. Virol. 85: 9051-9059.
28. Looney, R. J., A. R. Falsey, E. Walsh, and D. Campbell. 2002. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J. Infect. Dis. 185: 682-685.
29. de Bree, G. J., J. Heidema, E. M. van Leeuwen, G. M. van Bleek, R. E. Jonkers, H. M. Jansen, R. A. van Lier, and T. A. Out. 2005. Respiratory syncytial virusspecific CD8+ memory T cell responses in elderly persons. J. Infect. Dis. 191: 1710-1718.
30. Zhang, Y., Y. Wang, X. Gilmore, K. Xu, P. R. Wyde, and I. N. Mbawuike. 2002. An aged mouse model for RSV infection and diminished CD8(+) CTL responses. Exp. Biol. Med. (Maywood) 227: 133-140.
31. Tan, J. T., J. K. Whitmire, R. Ahmed, T. C. Pearson, and C. P. Larsen. 1999. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J. Immunol. 163: 4859-4868.
32. Weng, N. P., A. N. Akbar, and J. Goronzy. 2009. CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol. 30: 306-312.
33. Hurtado, J. C., Y. J. Kim, and B. S. Kwon. 1997. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activationinduced cell death. J. Immunol. 158: 2600-2609.
34. Schulz, M., R. M. Zinkernagel, and H. Hengartner. 1991. Peptide-induced antiviral protection by cytotoxic T cells. Proc. Natl. Acad. Sci. USA 88: 991-993.
35. Lee, H.W., S. J. Park, B. K. Choi, H. H. Kim, K. O. Nam, and B. S. Kwon. 2002. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. J. Immunol. 169: 4882-4888.
36. Wang, C., G. H. Lin, A. J. McPherson, and T. H. Watts. 2009. Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol. Rev. 229: 192-215.
37. Bertram, E. M., W. Dawicki, B. Sedgmen, J. L. Bramson, D. H. Lynch, and T. H. Watts. 2004. A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo. J. Immunol. 172: 981-988.
38. Zhao, Y., V. Tahiliani, S. Salek-Ardakani, and M. Croft. 2012. Targeting 4-1BB (CD137) to enhance CD8 T cell responses with poxviruses and viral antigens. Front. Immunol. 3: 332.
39. Chang, J., and T. J. Braciale. 2002. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat. Med. 8: 54-60.
40. Croft, M. 2009. The role of TNF superfamily members in T-cell function and diseases. Nat. Rev. Immunol. 9: 271-285.
41. Falsey, A. R., and E. E. Walsh. 1992. Humoral immunity to respiratory syncytial virus infection in the elderly. J. Med. Virol. 36: 39-43.
42. Walsh, E. E., and A. R. Falsey. 2012. Respiratory syncytial virus infection in adult populations. Infect. Disord. Drug Targets 12: 98-102.